首页 | 本学科首页   官方微博 | 高级检索  
     


Phase I study of combination recombinant interleukin-2 and interferon gamma in patients with advanced malignancies
Authors:E Hu  K Watkins  S Groshen  S C Chen  B Malloy  R Agah  P Nichols  J Parker  A Martin  M G Boosalis
Affiliation:Department of Hematology/Oncology, University of Southern California School of Medicine, Los Angeles.
Abstract:
A phase I trial of interleukin-2 and interferon gamma combination treatment in patients with advanced malignancies was performed based on preclinical in vitro and in vivo data which demonstrated synergistic antitumor effect. The toxicities, immune parameters, and tumor responses are described. The clinical and biologic maximal tolerated doses were extrapolated from these data.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号